Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$32.06 - $44.56 $419,986 - $583,736
13,100 New
13,100 $445,000
Q1 2023

May 15, 2023

BUY
$34.78 - $47.43 $104,340 - $142,290
3,000 Added 51.72%
8,800 $313,000
Q4 2022

Feb 14, 2023

BUY
$27.78 - $45.38 $161,124 - $263,204
5,800 New
5,800 $259,000
Q2 2022

Aug 15, 2022

BUY
$20.5 - $37.33 $344,400 - $627,144
16,800 Added 108.39%
32,300 $899,000
Q1 2022

May 16, 2022

BUY
$27.64 - $39.32 $96,740 - $137,620
3,500 Added 29.17%
15,500 $536,000
Q4 2021

Feb 14, 2022

BUY
$35.68 - $56.27 $221,216 - $348,874
6,200 Added 106.9%
12,000 $467,000
Q3 2021

Nov 12, 2021

BUY
$28.95 - $55.99 $167,910 - $324,742
5,800 New
5,800 $301,000
Q4 2020

Feb 12, 2021

SELL
$14.99 - $22.75 $344,770 - $523,250
-23,000 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$9.65 - $15.19 $113,870 - $179,242
11,800 Added 105.36%
23,000 $349,000
Q2 2020

Aug 13, 2020

SELL
$1.61 - $13.41 $1,127 - $9,387
-700 Reduced 5.88%
11,200 $140,000
Q1 2020

May 11, 2020

BUY
$1.55 - $3.07 $18,445 - $36,533
11,900 New
11,900 $21,000
Q4 2019

Feb 12, 2020

SELL
$2.11 - $2.8 $45,365 - $60,199
-21,500 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$2.05 - $2.75 $5,739 - $7,700
2,800 Added 14.97%
21,500 $47,000
Q2 2019

Aug 20, 2019

SELL
$2.43 - $5.09 $12,393 - $25,959
-5,100 Reduced 21.43%
18,700 $50,000
Q1 2019

May 15, 2019

BUY
$3.45 - $10.35 $82,110 - $246,330
23,800 New
23,800 $117,000

Others Institutions Holding CLDX

About Celldex Therapeutics, Inc.


  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.23B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.